Načítá se...
Neuroimaging Biomarkers for Alzheimer’s Disease
Currently, over five million Americans suffer with Alzheimer’s disease (AD). In the absence of a cure, this number could increase to 13.8 million by 2050. A critical goal of biomedical research is to establish indicators of AD during the preclinical stage (i.e. biomarkers) allowing for early diagnos...
Uloženo v:
| Vydáno v: | Mol Neurodegener |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6555939/ https://ncbi.nlm.nih.gov/pubmed/31174557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-019-0325-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|